HomeAI · summaries
Storia in 2 fonti
Semaglutide (Ozempic) linked to fewer bone fractures despite greater weight loss
A large real-world study suggests semaglutide (Ozempic, Wegovy, Rybelsus) may offer an unexpected bonus for people with type 2 diabetes: stronger protection against bone fractures while delivering greater weight loss. Researchers analyzing health records from nearly 60,000 adults found that people taking semaglutide experienced about 15% fewer fractures than those using other common weight-loss medications, despite losing more weight.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
fanpage.it
Semaglutide, perdere peso con i nuovi farmaci è associato a un rischio ridotto di malattie a reni, cuore e ossa
I ricercatori hanno determinato che la perdita di peso con i nuovi farmaci dimagranti - come la semaglutide - ha una forte associazione con la riduzione
- ·
sciencedaily.com
Semaglutide (Ozempic) linked to fewer bone fractures despite greater weight loss
A large real-world study suggests semaglutide (Ozempic, Wegovy, Rybelsus) may offer an unexpected bonus for people with type 2 diabetes: stronger protection against bone fractures…
- ·
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk
A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer.…